NEXTO NEXTO
Rezultatele cautarii
Vedeti tot
  • Conecteaza-te
    Conecteaza-te
    Inscrie-te
    Căutare
    Night Mode

Căutare

Descoperă oameni noi, creează noi conexiuni și faceti-va noi prieteni

  • News Feed
  • ECOSYSTEM
  • EXPLORE
  • Pagini
  • Grupuri
  • Events
  • Blogs
  • Postari
  • Blogs
  • Utilizatori
  • Pagini
  • Grupuri
  • Events
  • Reifide Wame a adăugat un sunet Health
    2025-11-12 09:53:53 -
    Charting the Future Trajectory: A Global Market Forecast for Transcatheter Heart Valve Replacement and Repair Devices Amidst Expanding Clinical Indications and Technological Innovations
      The global Transcatheter Market is poised for remarkable expansion, with industry estimates consistently pointing toward a robust double-digit Compound Annual Growth Rate (CAGR) through the next decade. This optimistic market trend is fundamentally rooted in the continued success and broader application of transcatheter heart valve (THV) therapies, particularly TAVR (Transcatheter Aortic...
    0 Commentarii 0 Distribuiri 352 Views 0 previzualizare
    Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
  • Atharva Patil a adăugat un sunet Health
    2026-04-09 06:22:55 -
    The Evolving Regulatory Landscape – FDA Approvals and Expanding Indications
    The regulatory pathway for Rituximab Biosimilars Market has matured significantly, with multiple products now approved across major jurisdictions. The U.S. Food and Drug Administration (FDA) has approved several rituximab biosimilars since 2017, including Celltrion’s Truxima, Pfizer’s Ruxience, and Amgen’s Riabni. These approvals have not only validated the...
    0 Commentarii 0 Distribuiri 6 Views 0 previzualizare
    Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
© 2026 NEXTO Romaian
English Arabic French Spanish Portuguese Deutsch Turkish Dutch Italiano Russian Romaian Portuguese (Brazil) Greek
About Termeni Confidențialitate Community Guidelines Tokenomics Roadmap & Updates Security & Safety Tips FAQ Cookie Policy Contacteaza-ne Director